Doxorubicin (DOX), a commonly used chemotherapy drug, is hindered due to its tendency to
induce cardiotoxicity (DIC). Ferroptosis, a novel mode of programmed cell death, has …

Doxorubicin (DOX) is an effective anthracycline chemotherapeutic anticancer drug with its
life-threatening cardiotoxicity severely limiting its clinical application. Mitochondrial damage …

Cardiotoxicity (CDTX) is a critical side effect of many cancer therapies, leading to increased
morbidity and mortality if not addressed. Early detection of CDTX is essential, and while …

Simple Summary Cancer therapy-related cardiac dysfunction (CTRCD) has been an urgent
medical issue in patients that receive breast cancer therapies including anthracycline-based …

Although anthracyclines are important anticancer agents, their use is limited due to various
adverse effects, particularly cardiac toxicity. Mechanisms underlying anthracycline-induced …

Cardiovascular disease, especially myocardial infarction, is a serious threat to human
health. Many drugs currently used cannot achieve the desired therapeutic effect due to the …

Cardiovascular diseases pose a serious threat to human health. The onset of cardiovascular
diseases involves the comprehensive effects of multiple genes and environmental factors …

Close monitoring for cardiotoxicity during anthracycline chemotherapy is crucial for early
diagnosis and therapy guidance. Currently, monitoring relies on cardiac imaging and serial …

Anthracyclines are widely used in the treatment of many solid cancers, but their efficacy is
limited by cardiotoxicity. As the number of pediatric cancer survivors continues to rise, there …

Aim: Possible roles of miRNAs in cancer treatment have been highly studied. This study
aimed to elucidate the role of miR-4732-3p in lung cancer. Methods: Bioinformatics analysis …